Your browser doesn't support javascript.
loading
The Titrated Mannitol Improved Central [99mTc] Tc TRODAT-1 Uptake in an Animal Model-A Clinically Feasible Application.
Chang, Kang-Wei; Chang, Po-Ling; Tsai, Chi-Jung; Tsai, Ya-Ju; Wu, Ping-Hsiu; Lee, Hsin-Lun; Lai, Yu-Hua; Wong, Ching-Yee Oliver; Huang, Wen-Sheng.
Afiliación
  • Chang KW; Taipei Neuroscience Institute & Laboratory Animal Center, Taipei Medical University, Taipei 11048, Taiwan.
  • Chang PL; Departments of Nuclear Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan.
  • Tsai CJ; Departments of Nuclear Medicine, Taipei Medical University Hospital, Taipei 11048, Taiwan.
  • Tsai YJ; Departments of Nuclear Medicine, Taipei Medical University Hospital, Taipei 11048, Taiwan.
  • Wu PH; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11048, Taiwan.
  • Lee HL; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei 11048, Taiwan.
  • Lai YH; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11048, Taiwan.
  • Wong CO; Department of Radiation Oncology, Taipei Medical University Hospital, Taipei 11048, Taiwan.
  • Huang WS; Department of Neurology, Cheng Hsin General Hospital, Taipei 11283, Taiwan.
Int J Mol Sci ; 24(4)2023 Feb 14.
Article en En | MEDLINE | ID: mdl-36835185
[99mTc]Tc TRODAT-1 is a widely used single photon emission tomography (SPECT) radiopharmaceutical in Asian practice for early detection of central dopaminergic disorders. However, its imaging quality remains sub-optimal. To overcome this problem, mannitol, an osmotic agent was used to observe its effect on improving striatal [99mTc]Tc TRODAT-1 uptake in rat brain by titrated human dosages to investigate a clinically feasible way to improve human imaging quality. [99mTc]Tc TRODAT-1 synthesis and quality control were performed as described. Sprague-Dawley rats were used for this study. The animal in vivo nanoSPECT/CT and ex vivo autoradiography were employed to observe and verify the striatal [99mTc]Tc TRODAT-1 uptake in rat brains using clinically equivalent doses (i.e., 0, 1 and 2 mL groups, each n = 5) of mannitol (20% w/v, equivalent to 200 mg/mL) by an intravenous administration. Specific binding ratios (SBRs) were calculated to express the central striatal uptake in different experimental groups. In the NanoSPECT/CT imaging, the highest SBRs of striatal [99mTc]Tc TRODAT-1 were reached at 75-90 min post-injection. The averaged striatal SBRs were 0.85 ± 0.13 (2 mL normal saline, the control group), 0.94 ± 0.26 (1 mL mannitol group) and 1.36 ± 0.12 (2 mL mannitol group, p < 0.01 which were significantly different than the control as well as 1 mL mannitol groups (p < 0.05). The SBRs from ex vivo autoradiography also showed a comparable trend of the striatal [99mTc]Tc TRODAT-1 uptake in the 2 mL, 1 mL mannitol and the control groups (1.76 ± 0.52, 0.91 ± 0.29, and 0.21 ± 0.03, respectively, p < 0.05). No remarkable changes of vital signs were found in the mannitol groups and the controls. Pre-treated mannitol revealed a significant increase of the central striatal [99mTc]Tc TRODAT-1 uptake in a rat model which not only enabled us to perform pre-clinical studies of dopaminergic related disorders but also provided a potential way to further optimize image quality in clinical practice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Organotecnecio / Proteínas de Transporte de Dopamina a través de la Membrana Plasmática Tipo de estudio: Screening_studies Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Compuestos de Organotecnecio / Proteínas de Transporte de Dopamina a través de la Membrana Plasmática Tipo de estudio: Screening_studies Límite: Animals / Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Taiwán